The Prognostic Characteristics and Recurrence Patterns of High Grade Endometrioid Endometrial Cancer: A Large Retrospective Analysis of a Tertiary Center

被引:3
|
作者
Zouridis, Andreas [1 ]
Zarrindej, Kianoush [2 ]
Rencher, Joshua [3 ]
Pappa, Christina [1 ]
Kashif, Ammara [1 ]
Smyth, Sarah Louise [1 ]
Sadeghi, Negin [1 ]
Sattar, Alisha [1 ]
Damato, Stephen [1 ]
Ferrari, Federico [4 ]
Lagana, Antonio Simone [5 ]
Abdalla, Mostafa [6 ]
Kehoe, Sean [1 ]
Addley, Susan [7 ]
Majd, Hooman Soleymani [1 ]
机构
[1] Oxford Univ Hosp NHS Fdn Trust, Oxford OX3 7LE, England
[2] Buckinghamshire NHS Fdn Trust, Wycombe HP11 2TT, Bucks, England
[3] Royal Berkshire NHS Fdn Trust, Reading RG1 5AN, England
[4] Univ Brescia, Dept Clin & Expt Sci, I-25136 Brescia, Italy
[5] Univ Palermo, Dept Hlth Promot Mother & Child Care, Internal Med & Med Specialties PROMISE, Unit Gynecol Oncol,ARNAS Civ Di Cristina Benfratel, I-90127 Palermo, Italy
[6] Guys & St Thomas NHS Fdn Trust, Gynaecol, London SE1 9RT, England
[7] Univ Hosp Derby & Burton NHS Fdn Trust, Derby DE22 3NE, England
关键词
endometrioid endometrial cancer; grade; 3; high grade; prognosis; recurrence; CLEAR-CELL CARCINOMAS; INITIATED FOLLOW-UP; GYNECOLOGICAL MALIGNANCY; SURVIVAL; RECOMMENDATIONS; ADENOCARCINOMA; GUIDELINES; FEATURES; THERAPY; IMPACT;
D O I
10.3390/jcm12093141
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High grade endometrioid endometrial cancer (HGEEC) is a heterogeneous group of tumors with unclear prognostic features. The aim of the present study is to evaluate the independent risk factors for recurrence and mortality and to describe the recurrence patterns of HGEEC. Ninety-six consecutive cases of HGEEC treated with primary surgery in a single Tertiary Center were retrospectively reviewed. Clinicopathological and treatment details were recorded, and all patients were closely followed up. Disease-free, overall and cancer-specific survival rates were 83.8%, 77.8% and 83.6%, respectively. Cervical stromal involvement was independently related to recurrence (HR = 25.67; 95%CI 2.95-223.30; p = 0.003) and cancer-related death (HR = 15.39; 95%CI 1.29-183.43; p = 0.031) after adjusting for other pathological and treatment variables. Recurrence rate was 16%, with 60% of these cases having lung metastases and only one case with single vaginal vault recurrence. 81.81% of the recurrences presented with symptoms and not a single recurrence was diagnosed in routine follow-up clinical examination. In conclusion, the recurrence pattern may suggest that patient-initiated follow-up (PIFU) could be considered a potential alternative to clinical-based follow-up for HGEEC survivors, especially for patients without cervical involvement and after two years from treatment. Additional caution is needed in patients with cervical stromal involvement.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] THE PROGNOSTIC CHARACTERISTICS AND RECURRENCE PATTERNS OF HIGH GRADE ENDOMETRIOID ENDOMETRIAL CANCER: A LARGE RETROSPECTIVE ANALYSIS OF A TERTIARY CENTER
    Zouridis, Andreas
    Zarrindej, Kianoush
    Rencher, Joshua
    Pappa, Christina
    Kashif, Ammara
    Smyth, Sarah Louise
    Sadeghi, Negin
    Sattar, Alisha Alisha
    Damato, Stephen
    Ferrari, Federico
    Lagana, Antonio Simone
    Abdalla, Mostafa
    Kehoe, Sean
    Addley, Susan
    Majd, Hooman Soleymani
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A203 - A203
  • [2] Prognostic significance of POLE exonuclease domain mutations in high grade endometrioid endometrial cancer on survival and recurrence
    Billingsley, C. C.
    Hade, E. M.
    Cohn, D. E.
    Mutch, D. G.
    Goodfellow, P. J.
    GYNECOLOGIC ONCOLOGY, 2015, 137 (03) : 591 - 592
  • [3] Challenging the Binary Classification of Endometrioid Endometrial Adenocarcinoma: The Evaluation of Grade 2 as an Independent Entity Based on Prognostic Characteristics and Recurrence Patterns
    Zouridis, Andreas
    Kashif, Ammara
    Darwish, Ahmed
    Pappa, Christina
    Ferrari, Federico
    Smyth, Sarah Louise
    Sadeghi, Negin
    Sattar, Alisha
    Damato, Stephen
    Abdalla, Mostafa
    Kehoe, Sean
    Addley, Susan
    Majd, Hooman Soleymani
    CANCERS, 2025, 17 (01)
  • [4] Patterns of recurrence of stage IC endometrioid endometrial cancer
    Long, K.
    Zhou, Q.
    Gomez, J.
    Alektiar, K.
    Gardner, G.
    Chi, D.
    Hensley, M.
    Barakat, R.
    Abu-Rustum, N.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S79 - S80
  • [5] Prognostic Significance of POLE Exonuclease Domain Mutations in High-Grade Endometrioid Endometrial Cancer on Survival and Recurrence A Subanalysis
    Billingsley, Caroline C.
    Cohn, David E.
    Mutch, David G.
    Hade, Erinn M.
    Goodfellow, Paul J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (05) : 933 - 938
  • [6] Unique prognostic features of grade 3 endometrioid endometrial carcinoma: Findings from 101 consecutive cases at a Japanese tertiary cancer center
    Kato, Mayumi Kobayashi
    Yoshida, Hiroshi
    Uehara, Takashi
    Uno, Masaya
    Ishikawa, Mitsuya
    Miyasaka, Naoyuki
    Kato, Tomoyasu
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2021, 60 (02): : 238 - 244
  • [7] Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma
    Wang, Jieyu
    Jia, Nan
    Li, Qing
    Wang, Chao
    Tao, Xiang
    Hua, Keqin
    Feng, Weiwei
    ONCOLOGY LETTERS, 2016, 12 (04) : 2860 - 2867
  • [8] Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer
    Long, Kara C.
    Zhou, Qin
    Hensley, Martee L.
    Alektiar, Kaled M.
    Gomez, Jacob
    Gardner, Ginger J.
    Chi, Dennis S.
    Barakat, Richard R.
    Abu-Rustum, Nadeem R.
    GYNECOLOGIC ONCOLOGY, 2012, 125 (01) : 99 - 102
  • [9] Analysis of prognostic factors in Grade 3 endometrioid type endometrial carcinoma
    Sahin, Eda Adeviye
    Toprak, Serhat
    Sayal, Hasan Berkan
    Ekinci, Tekin
    Yilmaz, Ercan
    Bakay, Kadir
    Melekoglu, Rauf
    Sezgin, Burak
    Tohma, Yusuf Aytac
    Sahin, Hanifi
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2022, 159 (03) : 719 - 726
  • [10] Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB
    Han, K. H.
    Kim, H. S.
    Song, Y. S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 990 - 990